The most read article from June through August was our interview with Jim Kababick from Flora Research Laboratories about the news that Bodybuilding.com has pled guilty to selling dietary supplements spiked with steroids - and agreed to pay a $7m fine.
According to Kababick, the news proved that FDA is “not blowing smoke” when it says it will crack down on adulterated products.
Please click here to read: Bodybuilding.com steroids spiking guilty plea is a wake-up call for industry, says lab director
The second most read of the summer so far was our report of a study from researchers from Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University and published in The Journal of Nutrition that indicated that low levels of vitamins B6 and B12 are associated with an increased risk of impaired cognition.
Please click here to read: Vitamin B6 and B12 levels linked to mental function and depression
Coming in at number 3, was our coverage of the emerging field of stem cell nutrition. In an interview with NutraIngredients-USA, Ray Carter Jr, CEO of Stemtech International, said the stem cell nutrition has the “potential to eclipse the massive antioxidant supplement business”.
Carter was speaking to NutraIngredients-USA after signing a multi-million dollar deal with Australian biotech firm Marinova to include its proprietary Fucoidan ingredients in Stemtech’s new ‘SE2’ supplement.
Please click here to read: Stemtech: Stem cell nutrition could eclipse antioxidant supplement market
Science was back in at number four with our article about a study from Harvard Medical School and Harvard School of Public Health, which suggested that the consumption of caffeinated coffee may be associated with a reduction in the risk of the most common form of skin cancer.
The study – published in Cancer Research – suggests that increasing the number of cups of caffeinated coffee you drink could lower your risk of developing basal cell carcinoma – the most common form of skin cancer.
Please click here to read: Coffee consumption could cut skin cancer risk
Science proved its popularity again with our article about resveratrol’s potential to help control blood sugar levels. Data published in Nutrition Research indicated that three months of consuming a daily supplement of resveratrol may help with blood sugar control and improve blood pressure in type-2 diabetics.
Improvements in Hemoglobin A1C, a marker of the long-term presence of excess glucose in the blood, were observed following three months of supplementation with 250 milligrams per day of resveratrol (Biofort, Biotivia Bioceuticals International) in combination with oral hypoglycemic agents.
Please click here to read: Resveratrol shows potential for blood sugar control: Human data